RedHill Biopharma (RDHL) Form 6-K Summary
RDHL announced a major legal victory: The New York Supreme Court awarded RedHill $10.5 Million against Kukbo Co. Ltd.
- $8.6 Million of the award is now final and immediately enforceable.
- An additional ~$1.9 Million for legal fees is subject to appeal until March 2026.
- 9% annual statutory interest continues to accrue.
- A Korean court attachment was granted to secure Kukbo’s assets prior to enforcement.
The company continues development/commercialization of:
- Talicia (H. pylori treatment).
- Late-stage pipeline ass